关于疫苗注射相关肩部损伤我们了解多少?一项更新的系统评价
该系统评价检索PubMed和Medline数据库,纳入42项研究(3项回顾性对照研究、5项数据库病例系列、34项病例报告),总结疫苗注射相关肩部损伤(SIRVA)的临床特征、诊断和治疗结局。最常见症状为肩痛和活动度受限,最常见诊断为肩峰下滑囊炎、粘连性肩关节囊炎和肩袖撕裂;根据最佳对照研究,炎症性肩部疾病与疫苗接种的关联似乎极为罕见,约每13万次疫苗接种事件后发生1例。典型治疗似乎有效,手术应很少进行。
要点
- SIRVA最常见症状为肩痛和活动度受限,最常见诊断为肩峰下滑囊炎、粘连性肩关节囊炎和肩袖撕裂。
- 最常用处理包括物理或作业治疗、非甾体抗炎药和类固醇注射,手术通常用于非手术治疗后症状持续者。
- 根据最佳对照研究,炎症性肩部疾病与疫苗接种的关联似乎极为罕见,约每13万次疫苗接种事件后发生1例。
核心结论
- 炎症性肩部疾病(如滑囊炎)与疫苗接种的关联似乎极为罕见,根据最佳对照研究约每13万次疫苗接种事件后发生1例。
- 目前没有确证性实验证据支持疫苗抗原引起免疫介导炎症反应的理论。
- 尽管临床证据有限,但与任何滑囊炎类似,典型治疗似乎有效,手术应很少进行。
- 需要额外研究以确定最佳注射技术或评估替代注射部位如大腿前外侧,以避免针头靠近肩部。
研究设计与样本
- 于2021年10月4日检索PubMed和Medline数据库中与SIRVA相关的研究。
- 纳入标准为涉及疫苗接种后发生肩痛的英文比较研究、病例系列和病例报告;排除仅研究疫苗接种后神经系统疾病的研究。
- 共42项研究符合纳入标准,包括3项回顾性对照研究(72例患者和105例对照)、5项数据库病例系列(2273例患者)和34项病例报告(49例患者)。
- 使用非随机研究方法学指数工具评估数据库病例系列和回顾性对照研究的研究质量。
主要发现
- 病例报告中患者中位年龄为51岁(范围15-90岁),73%(36/49)为女性。
- 病例报告中24%(12/49)的患者报告了BMI,中位数为23.5 kg/m2(范围21-37.2 kg/m2)。
- 最常见症状为肩痛和活动度受限。
- 最常见诊断为肩峰下滑囊炎、粘连性肩关节囊炎和肩袖撕裂。
- 症状完全缓解报告于2.9%至56%的患者。
关键数值与推荐
- 最常用处理方式包括物理或作业治疗、非甾体抗炎药和类固醇注射,其次为手术,手术通常用于非手术治疗后症状持续的患者。
临床怎么用
- 作者认为,与任何滑囊炎类似,典型治疗似乎有效,手术应很少进行。
- 作者认为,需要额外研究以确定最佳注射技术或评估替代注射部位如大腿前外侧,以避免针头靠近肩部。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Shoulder injury related to vaccine administration (SIRVA) is postulated to be an immune-mediated inflammatory response to a vaccine antigen injected into or near the subacromial bursae or synovium, leading to shoulder pain and dysfunction. The number of studies on this topic is rapidly increasing. Recent comparative studies have reported conflicting conclusions, which suggests that a systematic review of the best-available evidence may be helpful. QUESTIONS/PURPOSES: In this systematic review, we asked: What are the (1) clinical characteristics, (2) diagnoses, and (3) management approaches and outcomes reported in association with SIRVA? METHODS: A search was performed on October 4, 2021, of the PubMed and Medline databases for studies related to SIRVA. Inclusion criteria were English-language comparative studies, case series, and case reports that involved shoulder pain occurring after vaccination. Studies of exclusively neurologic conditions after vaccination were excluded. Forty-two studies met the eligibility criteria, including three retrospective comparative studies (72 patients and 105 controls), five database case series (2273 patients), and 34 case reports (49 patients). Study quality was assessed for the database case series and retrospective comparative studies using the Methodological Index for Non-randomized Studies tool. RESULTS: Among patients in the case reports, the median age was 51 years (range 15-90 years), and 73% (36 of 49) were women. BMI was reported for 24% of patients (12 of 49) in case reports, with a median of 23.5 kg/m2 (range 21-37.2 kg/m2). The most common symptoms were shoulder pain and reduced ROM. The most common diagnoses were shoulder bursitis, adhesive capsulitis, and rotator cuff tears. The most frequent management modalities included physical or occupational therapy, NSAIDs, and steroid injections, followed by surgery, which was generally used for patients whose symptoms persisted despite nonsurgical management. Full resolution of symptoms was reported in 2.9% to 56% of patients. CONCLUSION: The association between inflammatory conditions of the shoulder (such as bursitis) and vaccination appears to be exceedingly rare, occurring after approximately 1:130,000 vaccination events according to the best-available comparative study. Currently, there is no confirmatory experimental evidence supporting the theory of an immune-mediated inflammatory response to vaccine antigens. Although the clinical evidence is limited, similar to any bursitis, typical treatments appear effective, and surgery should rarely be performed. Additional research is needed to determine the best injection technique or evaluate alternate injection sites such as the anterolateral thigh that do not involve positioning a needle close to the shoulder.
引用
- MacMahon A, Nayar SK, Srikumaran U, et al. What Do We Know About Shoulder Injury Related to Vaccine Administration? An Updated Systematic Review. Clin Orthop Relat Res. 2022. PMID: 35323136. doi:10.1097/CORR.0000000000002181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。